Advertisement
Journal Home
Search for

Issue

Alert me when new journal issues are available via Request TOC Alert via emailor via Request RSS feed of current issue

previous issue next issue

Schizophrenia Research
Volume 96, Issue 1-3, Pages 1-276 (November 2007)
Search Within This Issue

display abstract citation download email a colleague
Display:

free full text =free full text


Editorial Board
page IFC
Full-Text PDF (43 KB)

Research papers


MRI brain volume abnormalities in young, nonpsychotic relatives of schizophrenia probands are associated with subsequent prodromal symptoms, 30 August 2007
Beng-Choon Ho
pages 1-13
Abstract | Full Text | Full-Text PDF (540 KB)


fMRI study of language activation in schizophrenia, schizoaffective disorder and in individuals genetically at high risk, 28 August 2007
Xiaobo Li, Craig A. Branch, Babak A. Ardekani, Hilary Bertisch, Chindo Hicks, Lynn E. DeLisi
pages 14-24
Abstract | Full Text | Full-Text PDF (520 KB)


Medium term follow-up of a randomized controlled trial of interventions for young people at ultra high risk of psychosis, 09 July 2007
Lisa J. Phillips, Patrick D. McGorry, Hok Pan Yuen, Janine Ward, Kerri Donovan, Daniel Kelly, Shona M. Francey, Alison R. Yung
pages 25-33
Abstract | Full Text | Full-Text PDF (251 KB)


In-vivo topography of structural alterations of the anterior cingulate in patients with schizophrenia: New findings and comparison with the literature, 03 September 2007
Thomas Zetzsche, Ulrich Preuss, Thomas Frodl, Dorothee Watz, Gisela Schmitt, Nikolaos Koutsouleris, Christine Born, Maximilian Reiser, Hans-Jürgen Möller, Eva Maria Meisenzahl
pages 34-45
Abstract | Full Text | Full-Text PDF (311 KB)


Differential alterations of kainate receptor subunits in inhibitory interneurons in the anterior cingulate cortex in schizophrenia and bipolar disorder, 15 August 2007
Tsung-Ung W. Woo, Kevin Shrestha, Christopher Amstrong, Martin M. Minns, John P. Walsh, Francine M. Benes
pages 46-61
Abstract | Full Text | Full-Text PDF (1109 KB)


Left posterior hippocampal density reduction using VBM and stereological MRI procedures in schizophrenia, 09 July 2007
Giuseppina Rametti, Nuria Segarra, Carme Junqué, Nuria Bargalló, Xavier Caldú, Naroa Ibarretxe, Miguel Bernardo
pages 62-71
Abstract | Full Text | Full-Text PDF (546 KB)


Developmental trajectories of brain structure in adolescents with 22q11.2 deletion syndrome: A longitudinal study, 05 September 2007
Doron Gothelf, Lauren Penniman, Eugene Gu, Stephan Eliez, Allan L. Reiss
pages 72-81
Abstract | Full Text | Full-Text PDF (428 KB)


Structural changes to the fusiform gyrus: A cerebral marker for social impairments in 22q11.2 deletion syndrome?, 10 September 2007
Bronwyn Glaser, Marie Schaer, Sandra Berney, Martin Debbane, Patrik Vuilleumier, Stephan Eliez
pages 82-86
Abstract | Full Text | Full-Text PDF (142 KB)


The catechol O-methyltransferase Val158Met polymorphism is not associated with broad-based cognitive functioning in schizophrenia, 09 July 2007
Faith B. Dickerson, John J. Boronow, Cassie Stallings, Andrea E. Origoni, Anne Sullens, Robert H. Yolken
pages 87-92
Abstract | Full Text | Full-Text PDF (154 KB)


Gene copy number variation in schizophrenia, 10 September 2007
Smitha R. Sutrala, Dirk Goossens, Nigel M. Williams, Lien Heyrman, Rolf Adolfsson, Nadine Norton, Paul R. Buckland, Jurgen Del-Favero
pages 93-99
Abstract | Full Text | Full-Text PDF (333 KB) | Add-Ons


Association of synapsin 2 with schizophrenia in families of Northern European ancestry, 03 September 2007
Viatcheslav Saviouk, Michael P. Moreau, Irina V. Tereshchenko, Linda M. Brzustowicz
pages 100-111
Abstract | Full Text | Full-Text PDF (209 KB) | Add-Ons


Association study between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia: A meta-analysis, 30 June 2007
Dawei Li, Lin He
pages 112-118
Abstract | Full Text | Full-Text PDF (265 KB) | Add-Ons


Association analysis of G72/G30 polymorphisms with schizophrenia in the Korean population, 28 July 2007
Hyoung Doo Shin, Byung Lae Park, Eun Mi Kim, Soo Ok Lee, Hyun Sub Cheong, Chang Hee Lee, Shin Gyeom Kim, Jin-Wook Sohn, Chul Soo Park, Jae Won Kim, Byung Hyo Kim, Im-Yel Kim, Ihn-Geun Choi, Sung-Il Woo
pages 119-124
Abstract | Full Text | Full-Text PDF (155 KB) | Add-Ons


Familial liability and schizophrenia phenotypes: A polydiagnostic approach, 03 September 2007
Victor Peralta, Manuel J. Cuesta
pages 125-134
Abstract | Full Text | Full-Text PDF (258 KB)


Impaired recognition and expression of emotional prosody in schizophrenia: Review and meta-analysis, 03 September 2007
Marjolijn Hoekert, René S. Kahn, Marieke Pijnenborg, André Aleman
pages 135-145
Abstract | Full Text | Full-Text PDF (302 KB)


Cognition, functioning and quality of life in schizophrenia treatment: Results of a one-year randomized controlled trial of olanzapine and quetiapine, 30 August 2007
L.P. Voruganti, A.G. Awad, G. Parker, C. Forrest, Y. Usmani, M.L.D. Fernando, S. Senthilal
pages 146-155
Abstract | Full Text | Full-Text PDF (181 KB)


Improved cognitive function in schizophrenia after one year of cognitive training and vocational services, 20 August 2007
Tamasine C. Greig, Wayne Zito, Bruce E. Wexler, Joanna Fiszdon, Morris D. Bell
pages 156-161
Abstract | Full Text | Full-Text PDF (141 KB)


Cognitive predictors of symptom change for participants in vocational rehabilitation, 03 September 2007
Morris D. Bell, Hector W.H. Tsang, Tamasine Greig, Gary Bryson
pages 162-168
Abstract | Full Text | Full-Text PDF (151 KB)


The neuropsychological correlates of cannabis use in schizophrenia: Lifetime abuse/dependence, frequency of use, and recency of use, 10 September 2007
Carissa M. Coulston, Michael Perdices, Christopher C. Tennant
pages 169-184
Abstract | Full Text | Full-Text PDF (266 KB)


Planning for the optimal design of studies to personalize antipsychotic prescriptions in the post-CATIE era: The clinical and pharmacoepidemiological data suggest that pursuing the pharmacogenetics of metabolic syndrome complications (hypertension, diabetes mellitus and hyperlipidemia) may be a reasonable strategy, 09 July 2007
Jose de Leon, Francisco J. Diaz
pages 185-197
Abstract | Full Text | Full-Text PDF (233 KB)


A pilot study of a weight management program with food provision in schizophrenia, 15 July 2007
Michel Jean-Baptiste, Cenk Tek, Ellen Liskov, Umesh Rao Chakunta, Sarah Nicholls, Akm Q. Hassan, Kelly D. Brownell, Bruce E. Wexler
pages 198-205
Abstract | Full Text | Full-Text PDF (196 KB)


Determinants of help-seeking and system related components of delay in the treatment of first-episode psychosis, 28 August 2007
Laura Bechard-Evans, Norbert Schmitz, Sherezad Abadi, Ridha Joober, Suzanne King, Ashok Malla
pages 206-214
Abstract | Full Text | Full-Text PDF (179 KB)


Dysglycemia in a community sample of people treated for schizophrenia: The Diabetes in Schizophrenia in Central-south Ontario (DiSCO) study, 31 August 2007
L.P. Voruganti, Z. Punthakee, R.J. Van Lieshout, D. MacCrimmon, G. Parker, A.G. Awad, H.C. Gerstein
pages 215-222
Abstract | Full Text | Full-Text PDF (199 KB)


Remission in schizophrenia: Applying recent consensus criteria to refine the concept, 03 September 2007
Robert A. Lasser, Henry Nasrallah, Lars Helldin, Joseph Peuskens, John Kane, John Docherty, Anselmo Toledo Tronco
pages 223-231
Abstract | Full Text | Full-Text PDF (166 KB)


Effectiveness of psychoeducation for relapse, symptoms, knowledge, adherence and functioning in psychotic disorders: A meta-analysis, 10 September 2007
T.M. Lincoln, K. Wilhelm, Y. Nestoriuc
pages 232-245
Abstract | Full Text | Full-Text PDF (376 KB)


A reduced number of cortical neurons show increased Caldendrin protein levels in chronic schizophrenia, 28 August 2007
Hans-Gert Bernstein, Jale Sahin, Karl-Heinz Smalla, Eckart D. Gundelfinger, Bernhard Bogerts, Michael R. Kreutz
pages 246-256
Abstract | Full Text | Full-Text PDF (858 KB)


The pro-apoptotic ARTS/Sept4 protein is significantly reduced in post-mortem brains from schizophrenic patients, 19 July 2007
Yossi Gottfried, Asaf Rotem, Ehud Klein, Sarit Larisch
pages 257-266
Abstract | Full Text | Full-Text PDF (694 KB)

Letters to the Editor


Neurotransmitter depleter tetrabenazine; potential candidate for schizophrenia treatment?, 20 August 2007
Abid Malik, Victoria Balkoski
pages 267-268
Full Text | Full-Text PDF (98 KB)


Omega-3 and violence in schizophrenia, 16 July 2007
Nancy Légaré, Élaine Brosseau, Christian C. Joyal
page 269
Full Text | Full-Text PDF (93 KB)


Possible psychotropic effects of Aripiprazole, 03 September 2007
Ronald Bottlender, Mike O'Donnell
page 270
Full Text | Full-Text PDF (86 KB)


A possible link between dopamine action and myelin dysfunction in schizophrenia, 30 August 2007
Eva Lindholm, Elena Jazin
pages 271-272
Full Text | Full-Text PDF (145 KB)

Corrigendum


Corrigendum to “Efficacy, safety and early response of paliperidone extended-release tablets (paliperidone ER): Results of a 6-week, randomized, placebo-controlled study” [Schizophrenia Research 93 (1–3) (2007) 117–130], 15 August 2007 free full text
Michael Davidson, Robin Emsley, Michelle Kramer, Lisa Ford, Guohua Pan, Pilar Lim, Mariëlle Eerdekens
pages 273-274
Full Text | Full-Text PDF (170 KB)

display abstract citation download email a colleague
Display:
Advertisement